Analysen von Emmanuel Papadakis

31.10.19 Sanofi Equal weight Barclays Capital
25.10.19 Bayer overweight Barclays Capital
25.10.19 Novartis Underweight Barclays Capital
17.10.19 Roche overweight Barclays Capital
09.10.19 Bayer overweight Barclays Capital
26.09.19 Sanofi Equal weight Barclays Capital
26.09.19 GSK Equal weight Barclays Capital
26.09.19 Bayer overweight Barclays Capital
23.09.19 Novo Nordisk Equal weight Barclays Capital
13.09.19 AstraZeneca overweight Barclays Capital
09.09.19 Roche overweight Barclays Capital
06.09.19 AstraZeneca overweight Barclays Capital
05.09.19 Novartis Underweight Barclays Capital
16.08.19 Bayer overweight Barclays Capital
16.08.19 AstraZeneca overweight Barclays Capital
09.08.19 AstraZeneca overweight Barclays Capital
09.08.19 Novo Nordisk Equal weight Barclays Capital
05.08.19 Roche overweight Barclays Capital
31.07.19 Bayer overweight Barclays Capital
30.07.19 Bayer overweight Barclays Capital
26.07.19 AstraZeneca overweight Barclays Capital
19.07.19 Novartis Underweight Barclays Capital
11.06.19 Novo Nordisk Equal weight Barclays Capital
24.05.19 Bayer overweight Barclays Capital
24.05.19 Roche overweight Barclays Capital
24.05.19 AstraZeneca overweight Barclays Capital
17.05.19 Novo Nordisk Underweight Barclays Capital
14.05.19 Bayer overweight Barclays Capital
06.05.19 Novo Nordisk Underweight Barclays Capital
26.04.19 Bayer overweight Barclays Capital
10.04.19 Bayer overweight Barclays Capital
10.04.19 Novartis Underweight Barclays Capital
08.04.19 Novartis Underweight Barclays Capital
08.04.19 Merck Underweight Barclays Capital
29.03.19 AstraZeneca overweight Barclays Capital
21.03.19 Bayer overweight Barclays Capital
20.03.19 Bayer overweight Barclays Capital
19.03.19 Roche overweight Barclays Capital
01.03.19 Bayer overweight Barclays Capital
27.02.19 Bayer overweight Barclays Capital
26.02.19 AstraZeneca overweight Barclays Capital
25.02.19 AstraZeneca overweight Barclays Capital
25.02.19 Bayer overweight Barclays Capital
25.02.19 Roche overweight Barclays Capital
05.02.19 Novo Nordisk verkaufen Barclays Capital
01.02.19 Novartis Underweight Barclays Capital
29.01.19 Roche overweight Barclays Capital
18.01.19 Bayer overweight Barclays Capital
16.01.19 Novartis Underweight Barclays Capital
15.01.19 Merck Underweight Barclays Capital